Emma Vickerstaffe

Person

Baldock, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Bicyclic heterocyclic compounds as FGFR inhibitors
- Patent number 8,895,745
- Issue date Nov 25, 2014
- Astex Therapeutics Limited
- Valerio Berdini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
- Patent number 8,859,582
- Issue date Oct 14, 2014
- Astex Therapeutics Limited
- Gordon Saxty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
- Patent number 8,859,583
- Issue date Oct 14, 2014
- Astex Therapeutics Limited
- Gordon Saxty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
- Patent number 8,796,244
- Issue date Aug 5, 2014
- Astex Therapeutics Ltd.
- Valerio Berdini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo[1,2-a]pyridine compounds for use in treating cancer
- Patent number 8,513,276
- Issue date Aug 20, 2013
- Astex Therapeutics Limited
- Valerio Berdini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
- Patent number 8,076,354
- Issue date Dec 13, 2011
- Astex Therapeutics Limited
- Gordon Saxty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
- Patent number 8,071,614
- Issue date Dec 6, 2011
- Astex Therapeutics Limited
- Gordon Saxty
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES
- Publication number 20120208791
- Publication date Aug 16, 2012
- ASTEX THERAPEUTICS LIMITED
- Valerio Berdini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
- Publication number 20120035152
- Publication date Feb 9, 2012
- ASTEX THERAPEUTICS LIMITED
- Gordon Saxty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
- Publication number 20120035153
- Publication date Feb 9, 2012
- ASTEX THERAPEUTICS LIMITED
- Gordon Saxty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
- Publication number 20100331296
- Publication date Dec 30, 2010
- ASTEX THERAPEUTICS LIMITED
- Gordon Saxty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS
- Publication number 20100286113
- Publication date Nov 11, 2010
- ASTEX THERAPEUTICS LIMITED
- Gordon Saxty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic Heterocyclic Compounds as FGFR Inhibitors
- Publication number 20100120761
- Publication date May 13, 2010
- ASTEX THERAPEUTICS LIMITED
- Valerio Berdini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds
- Publication number 20100093718
- Publication date Apr 15, 2010
- Valerio Berdini
- C07 - ORGANIC CHEMISTRY

Emma Vickerstaffe

Person

Patents Grantslast 30 patents

Bicyclic heterocyclic compounds as FGFR inhibitors

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors

Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases

Imidazo[1,2-a]pyridine compounds for use in treating cancer

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors

Patents Applicationslast 30 patents

IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES

BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS

BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS

BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS

BICYCLIC HETEROCYCLIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS

Bicyclic Heterocyclic Compounds as FGFR Inhibitors

Compounds